After four weeks of treatment, CT-996 demonstrated clinically meaningful weight loss of -7.3% (weight loss in placebo -1.2%; p <…
ORIC-944, a potential best-in-class PRC2 inhibitor, is being evaluated in combination with darolutamide and in combination with apalutamide in patients…
FOSTER CITY, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical…
VANCOUVER, BC / ACCESSWIRE / July 17, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to…
SenderraCare+ is a game-changer for providers and patients alike. It simplifies the time-consuming process and offers a real-time digital solution…
CHENGDU, China, July 16, 2024 /PRNewswire/ -- "Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery" webinar will be…
CHICAGO, July 16, 2024 /PRNewswire/ -- The global pharmaceutical inspection machines market is projected to grow from USD 0.9 billion in…
Dario's leading behavior change solutions continue to win interest in the employer, payer and pharmaceutical markets NEW YORK, July 16,…
- Mr. Lee joins the company to spearhead its next phase of data-driven solutions - BASKING RIDGE, N.J., July 16,…
MORRISVILLE, N.C., July 16, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety…